EUVIMEDEUVIMED entdecken
Kontrollierte klinische StudieOpen Access · CC BY-NC 4.0

Effects of a Gel Containing the Defined Microalgae Extract Spiralin® on the Skin Microbiome and Clinical Activity in Atopic Dermatitis: A Double-Blind, Intraindividual Vehicle-Controlled Proof-Of-Concept Study

Kristian Reich, Natalie Trettel, Jeremias L K Reich, Christina Sorbe, Thomas Bickert, Jan Hartmann, Inken Harder, Sascha Gerdes, Stephan Weidinger

Skin Pharmacology and Physiology · 2025

DOI: 10.1159/000547835 ↗

Kurz gefasst

Kontrollierte klinische Studie in der Zeitschrift Skin Pharmacology and Physiology, 2025. Verfasst von Kristian Reich und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research in Inflammatory Skin Diseases, Institute for Health Care Research in Dermatology and Nursing, University Medical Center Hambur…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Microalgae, Skin, Skin Microbiome. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Changes in the skin microbiome in atopic dermatitis (AD) include a reduced bacterial diversity and increased abundance of Staphylococcus aureus. Topical antibiotics and antiseptics may decrease bacterial pathogens but lack positive effects on microbiome diversity.

Methods

In this double-blind, intraindividual vehicle-controlled proof-of-concept study, n = 20 patients received a gel containing a defined extract (Spiralin®) of the microalgae Spirulina platensis, previously shown to exert anti-microbial effects, or vehicle on target lesions of similar size and clinical activity. The Shannon index reflecting α-diversity and the abundance of S. aureus were calculated from the analysis of 16s rRNA gene libraries with untreated non-lesional skin serving as control. Clinical activity was determined by the Target Lesion Severity Score (TLSS) and lesion size.

Results

Positive effects of the active gel on the microbiome after 4 weeks of treatment were indicated by a significant increase of the Shannon index in areas treated with verum (mean increase 16.7%; p < 0.01 vs. baseline), but not in areas treated with vehicle. This increase in verum-treated lesions was more pronounced in lesions with an at least 50% (26.3%) or an at least 75% reduction of the TLSS (33.3%). There was also a stronger decrease of the abundance of S. aureus in lesions treated with active gel compared to those treated with vehicle (25.5% vs. 9.4%), but significance was not met. There were several trends, indicating clinical effects of the active gel. For example, vehicle-treated areas showed no reduction in area size (77.8 cm2 at week 4 compared to 77.0 cm2 at baseline), while verum-treated lesion area decreased on average by 6.9 cm2. Active and vehicle gel were well tolerated, and very few local side effects were noted.

Conclusion

These preliminary results indicate a positive effect of a gel-containing Spiralin® on the skin microbiome in patients with active AD lesions combined with reductions in clinical disease activity, supporting further investigations of the active gel alone or in combination with anti-inflammatory treatments in larger AD studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicMicroalgaeSkinSkin MicrobiomeSpirulinaAdultFemaleHumansMaleMiddle AgedYoung AdultDouble-Blind MethodGelsMicrobiotaProof of Concept StudyStaphylococcus aureus

Stichwörter der Autor:innen

Atopic dermatitisImmune systemSkin microbiomeSpiralin®

Substanzen

Gels

Autor:innen und Institutionen

  • Translational Research in Inflammatory Skin Diseases, Institute for Health Care Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, k.reich@uke.de.
  • Institute for Health Care Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Oxford University Clinical Academic Graduate School, Oxford University, McKinsey & Company, Inc, Oxford, UK.
  • Department of Dermatology, University Clinic Schleswig-Holstein, Campus Kiel, Kiel, Germany.

Zitieren

APA

Reich, K., Trettel, N., Reich, J. L. K., Sorbe, C., Bickert, T., Hartmann, J., Harder, I., Gerdes, S., & Weidinger, S. (2025). Effects of a Gel Containing the Defined Microalgae Extract Spiralin® on the Skin Microbiome and Clinical Activity in Atopic Dermatitis: A Double-Blind, Intraindividual Vehicle-Controlled Proof-Of-Concept Study. Skin Pharmacology and Physiology. https://doi.org/10.1159/000547835

Vancouver

Reich K, Trettel N, Reich JLK, Sorbe C, Bickert T, Hartmann J, et al. Effects of a Gel Containing the Defined Microalgae Extract Spiralin® on the Skin Microbiome and Clinical Activity in Atopic Dermatitis: A Double-Blind, Intraindividual Vehicle-Controlled Proof-Of-Concept Study. Skin Pharmacology and Physiology. 2025. doi:10.1159/000547835

BibTeX
@article{Reich2025,
  author = {Reich, Kristian and Trettel, Natalie and Reich, Jeremias L K and Sorbe, Christina and Bickert, Thomas and Hartmann, Jan and Harder, Inken and Gerdes, Sascha and Weidinger, Stephan},
  title = {Effects of a Gel Containing the Defined Microalgae Extract Spiralin® on the Skin Microbiome and Clinical Activity in Atopic Dermatitis: A Double-Blind, Intraindividual Vehicle-Controlled Proof-Of-Concept Study},
  journal = {Skin Pharmacology and Physiology},
  year = {2025},
  doi = {10.1159/000547835}
}
Kostenlos starten →